<i>WNT6</i> is a novel oncogenic prognostic biomarker in human glioblastoma.

Theranostics · 2018 · PMC6160775 · PMID 30279739

Europe PMC DOI

hedged sentence

0.0690

closest p · 1.4× alpha

0.0690

boldest claim

The sentences

an evident trendp = 0.069so close (0.05 < p ≤ 0.1)

Moreover, high levels of WNT6 protein expression, evaluated by IHC in a GBM Brazilian cohort (n = 87), also showed an evident trend for shorter OS ( p = 0.069; Figure S7 ), highlighting that both mRNA and protein levels of WNT6 may be used as a clinically valuable biomarker.

also in 268 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.